Home › Hemophilia B › California › San Diego
Hemophilia B clinical trials in San Diego, CA
3 studies for Hemophilia B are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
RecruitingPhase 3
- Rady Children's Hospital San Diego, San Diego
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
RecruitingPhase 3
- University of California, San Diego (UCSD), San Diego
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
- Hemophilia & Thrombosis Treatment Center at UC San Diego Health, San Diego
- Rady Children's Hospital San Diego, San Diego
Hemophilia B trials in other cities
- Philadelphia, PA5 studies
- Sacramento, CA4 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- Ann Arbor, MI4 studies
- Nashville, TN3 studies
- Gainesville, FL3 studies
- Greenville, NC3 studies
- Atlanta, GA3 studies
- Seattle, WA3 studies
- San Francisco, CA3 studies
- Indianapolis, IN3 studies
Other studies in San Diego
- Non-Small Cell Lung Cancer49 studies
- Breast Cancer41 studies
- Prostate Cancer32 studies
- Cancer (all types)31 studies
- Metastatic Cancer29 studies
- Lung Cancer26 studies
- Pancreatic Cancer24 studies
- Obesity24 studies
- Ovarian Cancer24 studies
- Colorectal Cancer22 studies
- Heart Failure22 studies
- Type 2 Diabetes21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.